[go: up one dir, main page]

CA2015536A1 - Formule pharmaceutique - Google Patents

Formule pharmaceutique

Info

Publication number
CA2015536A1
CA2015536A1 CA2015536A CA2015536A CA2015536A1 CA 2015536 A1 CA2015536 A1 CA 2015536A1 CA 2015536 A CA2015536 A CA 2015536A CA 2015536 A CA2015536 A CA 2015536A CA 2015536 A1 CA2015536 A1 CA 2015536A1
Authority
CA
Canada
Prior art keywords
medicament
pharmaceutical formulation
chewable
tablet
chewability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2015536A
Other languages
English (en)
Other versions
CA2015536C (fr
Inventor
David Roy Merrifield
Ian James Bolt
Paul Laurence Carter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of CA2015536A1 publication Critical patent/CA2015536A1/fr
Application granted granted Critical
Publication of CA2015536C publication Critical patent/CA2015536C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
CA002015536A 1989-04-28 1990-04-26 Formule pharmaceutique Expired - Fee Related CA2015536C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8909793.5 1989-04-28
GB898909793A GB8909793D0 (en) 1989-04-28 1989-04-28 Pharmaceutical formulation

Publications (2)

Publication Number Publication Date
CA2015536A1 true CA2015536A1 (fr) 1990-10-28
CA2015536C CA2015536C (fr) 1999-08-24

Family

ID=10655920

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002015536A Expired - Fee Related CA2015536C (fr) 1989-04-28 1990-04-26 Formule pharmaceutique

Country Status (17)

Country Link
US (2) US5225197A (fr)
EP (1) EP0396335B1 (fr)
JP (1) JP2992761B2 (fr)
KR (1) KR0167554B1 (fr)
AT (1) ATE101034T1 (fr)
AU (1) AU627298B2 (fr)
CA (1) CA2015536C (fr)
CY (1) CY1957A (fr)
DE (1) DE69006385T2 (fr)
DK (1) DK0396335T3 (fr)
ES (1) ES2062353T3 (fr)
GB (1) GB8909793D0 (fr)
HK (1) HK1004522A1 (fr)
IE (1) IE63806B1 (fr)
NZ (1) NZ233441A (fr)
PT (1) PT93877B (fr)
ZA (1) ZA903181B (fr)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2633181B1 (fr) * 1988-06-24 1992-01-10 Glaxo Lab Sa Composition pharmaceutique a base de ranitidine et son procede de preparation
US5223264A (en) * 1989-10-02 1993-06-29 Cima Labs, Inc. Pediatric effervescent dosage form
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
AU646232B2 (en) * 1989-10-02 1994-02-17 Cima Labs, Inc. Effervescent dosage form and method of administering same
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
US5744500A (en) * 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
US5814337A (en) * 1992-10-07 1998-09-29 Beecham Group Plc Pharmaceutical formulation
GB9009473D0 (en) 1990-04-27 1990-06-20 Beecham Group Plc Pharmaceutical formulation
US5670170A (en) * 1990-04-27 1997-09-23 Beecham Group P.L.C. Pharamaceutical formulation
GB9027827D0 (en) * 1990-12-21 1991-02-13 Glaxo Laboratoires Pharmaceutical compositions
US5468504A (en) * 1990-12-21 1995-11-21 Laboratoires Glaxo S.A. Effervescent pharmaceutical compositions
JPH06505498A (ja) * 1991-04-04 1994-06-23 ザ、プロクター、エンド、ギャンブル、カンパニー 咀嚼性制酸組成物
GB9108128D0 (en) * 1991-04-15 1991-06-05 Zambeletti Spa L Novel formulation
EP0574624B1 (fr) * 1992-06-17 1997-09-10 Laboratoires Glaxo Sa Compositions pharmaceutiques
US5330760A (en) * 1992-08-27 1994-07-19 Sterling Winthrop Inc. Effervescent antacid
ZA939117B (en) * 1992-12-04 1994-08-05 Susanna Elizabeth Chalmers Pharmaceutical product
HU217125B (hu) * 1993-03-10 1999-11-29 Béres Rt. Cukor- és nátriummentes pezsgőtabletta és -granulátum és eljárás azok előállítására
AU699192B2 (en) * 1993-08-13 1998-11-26 Bayer Corporation Hydrolyzed gelatin as a flavor enhancer in a chewable tablet
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
FR2709420B1 (fr) * 1993-09-01 1995-11-17 Sogeval Comprimé vétérinaire plus spécialement destiné aux chats.
FI103442B1 (fi) * 1993-09-24 1999-06-30 Nokia Telecommunications Oy Digitaalinen radiolinkkijärjestelmä ja radiolinkkilaite
IL112779A (en) * 1994-03-01 1999-11-30 Gergely Gerhard Granular product or tablet containing an efferescent system and an active pharmaceutical substance and its preparation
US5399356A (en) * 1994-03-24 1995-03-21 The Procter & Gamble Company Process for making solid dose forms containing bismuth
WO1996037182A1 (fr) * 1995-05-26 1996-11-28 Tom Kalili Chewing-gum contenant du fluorure et de l'acide nitrique
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
FR2732217B1 (fr) * 1995-03-29 1997-06-06 Hesnard Xavier Forme d'administration solide a usage oral
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
SK74396A3 (en) * 1995-06-13 1997-04-09 American Home Prod Organoleptically acceptable oral pharmaceutical compositions
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
NZ337247A (en) * 1995-09-07 2001-05-25 Smithkline Beecham Corp Pharmaceutical tablet formulation comprising 875mg amoxycillin
IL115357A (en) * 1995-09-20 2000-01-31 Teva Pharma Stable compositions containing N-propargyl-1-aminoindan and polyhydric alcohols
US5807577A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
DE69727922T2 (de) * 1996-04-16 2005-01-20 Novartis Consumer Health S.A. Schnell zerfallende orale dosierungsform
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
FR2753097A1 (fr) * 1996-09-11 1998-03-13 Barrau Francois Gel aqueux ou hydroalcoolique extemporane a viscosite controlee
US6488961B1 (en) 1996-09-20 2002-12-03 Ethypharm, Inc. Effervescent granules and methods for their preparation
US6649186B1 (en) 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
US5837286A (en) * 1997-01-15 1998-11-17 Pandya; Harish B. Taste masking for unplatable formulations
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
US6024981A (en) 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
US6667056B2 (en) 1997-07-23 2003-12-23 Chiesi Farmaceutici S.P.A. Pharmaceutical compositions containing an effervescent acid-base couple
US6673380B2 (en) 1998-11-17 2004-01-06 Mcneil-Ppc, Inc. Fortified confectionery delivery systems and methods of preparation thereof
WO1999043306A1 (fr) * 1998-02-26 1999-09-02 Banyu Pharmaceutical Co., Ltd. Composition a desintegration orale et son procede de fabrication
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US20030091629A1 (en) 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
DE19814257A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
WO1999063970A1 (fr) * 1998-06-11 1999-12-16 Pharmacia & Upjohn Company Formulation de delavirdine en comprime
US6365182B1 (en) 1998-08-12 2002-04-02 Cima Labs Inc. Organoleptically pleasant in-mouth rapidly disintegrable potassium chloride tablet
US6296868B1 (en) * 1998-11-19 2001-10-02 Advanced Technology Pharmaceuticals Corporation Chewable tablets containing mannitol and aspartame
FR2786395A1 (fr) * 1998-12-01 2000-06-02 Virbac Sa Compositions seches solubles en presence d'eau et evitant la reaction de maillard a l'etat sec, leur preparation et leurs applications
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US20020006433A1 (en) * 1999-04-29 2002-01-17 Nigel P. Davidson Pharmaceutical formulations
US6589555B2 (en) 1999-12-29 2003-07-08 Mahendra Pandya Effervescent vitaceutical compositions and related methods
PT1309315E (pt) * 2000-08-18 2006-09-29 Pharmacia Corp Formulacao oral de desintegracao rapida de valdecoxib
AU2001292185A1 (en) 2000-10-12 2002-04-22 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
CA2436570A1 (fr) * 2000-12-06 2002-06-13 Pharmacia Corporation Composition pharmaceutique a dispersion rapide
WO2003063840A2 (fr) * 2002-01-25 2003-08-07 Santarus, Inc. Administration par voie muqueuse d'inhibiteurs de la pompe a protons
ES2302926T5 (es) 2002-04-25 2012-08-23 Banner Pharmacaps, Inc. Cápsula blanda masticable
US7189416B2 (en) * 2002-11-23 2007-03-13 Glykon Technologies Group, Llc Method for stable and controlled delivery of (-)-hydroxycitric acid
US20040223921A1 (en) * 2003-05-07 2004-11-11 Rau Allen H. Oral care tablet
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2005021056A1 (fr) * 2003-08-21 2005-03-10 Cns, Inc. Systeme de distribution de materiau effervescent
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
WO2005051350A2 (fr) * 2003-10-28 2005-06-09 Torrent Pharmaceuticals Limited Comprime dispersible dans l'eau
US20070048375A1 (en) * 2003-12-19 2007-03-01 Wolfgang Wiehl Effervescent preparation of a basic medicinally active substance
CN102078310B (zh) 2003-12-31 2013-01-23 奇马实验室公司 大体线性的泡腾口服芬太尼剂型和施用方法
US7858121B2 (en) 2003-12-31 2010-12-28 Cima Labs, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
AU2004311879B2 (en) 2003-12-31 2010-08-05 Phoenix Labs Unlimited Company Effervescent oral opiate dosage form
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
ES2624585T3 (es) * 2004-05-28 2017-07-17 Imaginot Pty Ltd. Sistema de suministro de compuesto terapéutico oral
CN1968682A (zh) * 2004-06-18 2007-05-23 株式会社柳韩洋行 包含表面改性的碳酸氢钠的阿莫西林和/或克拉维酸口服分散片组合物
CA2629904C (fr) * 2005-11-28 2018-07-10 Imaginot Pty Ltd. Systeme d'administration orale de compose therapeutique
US7611739B2 (en) * 2006-01-06 2009-11-03 Amerilab Technologies, Inc. Method of using guava extract and composition including guava extract
US20090004270A1 (en) * 2006-01-06 2009-01-01 Amerilab Technologies, Inc. Method of using guava extract
US20070298078A1 (en) * 2006-06-27 2007-12-27 Harrison Michael D Water Soluble Article for Imparting Dietary Fiber to Bottled Water
US12403095B2 (en) 2008-05-30 2025-09-02 Veloxis Pharmaceuticals, Inc. Stabilized tacrolimus composition
WO2011100975A2 (fr) * 2010-02-17 2011-08-25 Lifecycle Pharma A/S Composition à base de tacrolimus stabilisée
EP2649989B1 (fr) 2012-04-13 2017-10-18 King Saud University Procédé de préparation d'une dispersion solide, dispersion solide ainsi obtenue et son utilisation
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
AU2013274378B2 (en) 2012-06-12 2016-06-02 The Procter & Gamble Company Effervescent dosage form
JP6253393B2 (ja) * 2013-12-19 2017-12-27 花王株式会社 固形状組成物
WO2020070236A1 (fr) 2018-10-04 2020-04-09 Adeptio Pharmaceuticals Limited Régime posologique de (+)-alpha-dihydrotétrabénazine destiné au traitement de troubles du mouvement

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1098116A (fr) * 1954-01-07 1955-07-18 Marocaine De Prod Chim Et Agri Procédé de fabrication de glossettes contenant des compositions destinées à l'absorption intratissulaire
US3039922A (en) * 1959-08-17 1962-06-19 Carter Prod Inc Method of administering tablets having decongestant and anti-histaminic activity
FR2294M (fr) * 1962-07-30 1964-01-27 Dausse Lab Composition a base de sorbitol.
GB1113492A (en) * 1964-05-20 1968-05-15 Bristol Myers Co Chewable tablets comprising a penicillin antibiotic
SE369036B (fr) * 1972-06-30 1974-08-05 Astra Laekemedel Ab
US4127645A (en) * 1976-05-21 1978-11-28 Life Savers, Inc. Effervescent tablet and method
US4639368A (en) * 1984-08-23 1987-01-27 Farmacon Research Corporation Chewing gum containing a medicament and taste maskers
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4704269A (en) * 1985-06-11 1987-11-03 Hudson Pharmaceutical Corporation Effervescent antacid and analgesic compositions
US4832956A (en) * 1985-09-25 1989-05-23 Gerhard Gergely Disintegrating tablet and process for its preparation
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles

Also Published As

Publication number Publication date
CA2015536C (fr) 1999-08-24
EP0396335A1 (fr) 1990-11-07
AU5391490A (en) 1990-11-01
KR900015716A (ko) 1990-11-10
JPH02295919A (ja) 1990-12-06
GB8909793D0 (en) 1989-06-14
JP2992761B2 (ja) 1999-12-20
US5962022A (en) 1999-10-05
IE901489L (en) 1990-10-28
DE69006385T2 (de) 1994-05-19
IE63806B1 (en) 1995-06-14
PT93877A (pt) 1990-11-20
DK0396335T3 (da) 1994-03-07
EP0396335B1 (fr) 1994-02-02
KR0167554B1 (ko) 1999-01-15
DE69006385D1 (de) 1994-03-17
ATE101034T1 (de) 1994-02-15
CY1957A (en) 1990-04-26
HK1004522A1 (en) 1998-11-27
AU627298B2 (en) 1992-08-20
NZ233441A (en) 1992-03-26
PT93877B (pt) 1996-09-30
ES2062353T3 (es) 1994-12-16
ZA903181B (en) 1991-06-26
US5225197A (en) 1993-07-06

Similar Documents

Publication Publication Date Title
CA2015536A1 (fr) Formule pharmaceutique
CA2061917A1 (fr) Forme posologique effervescente pour enfants
CA2232450A1 (fr) Composition pharmaceutique administrable par voie orale contenant des agents actifs antimicrobiens et du pantoprazole a liberation differee
USD301166S (en) Mattress for endoscopic examination
CA2281473A1 (fr) Forme galenique presentant des proprietes de dispersion rapide, ses procedes d'utilisation et son procede de preparation
ATE297191T1 (de) Im munde schnellzerfallende tablette
CA2180816A1 (fr) 6-dimethylaminomethyl-1-phenylcyclohexanes, principes actifs en pharmacie
CA2193337A1 (fr) Composes de type 1-phenyl-2-dimethylaminomethylcyclohexan-1-o1, ingredients pharmaceutiques actifs
CA2258095A1 (fr) Compositions contenant de la tetrahydrolipstatine
CA2102630A1 (fr) Compositions pharmaceutiques de medicaments compactes
CA2103443A1 (fr) Composition a macher pour l'administration de medicaments
HUT55220A (en) Process for producing pharmaceutical composition suitable for systemic administration through the skin and comprising deprenyl as active ingredient
CA2186039A1 (fr) Nouvelle forme galenique pharmaceutique orale
HUP9903613A3 (en) Improvement in the taste of active pharmaceutical ingredients
IE882960L (en) Osmotic dosage form for administering isradipine
CA2204180A1 (fr) Formulations a pouvoir therapeutique obtenues par extrusion de matiere fondue et administrables par voie orale
AU7378987A (en) Drug delivery device, its preparation and use
CA2274485A1 (fr) Compositions medicinales
CA2301176A1 (fr) Compositions formees par cisaillement, a auto-liaison
IL159217A0 (en) An oral pharmaceutical formulation comprising a basic pharmaceutically active ingredient having ph-dependent solubility, a process for the manufacture thereof and use thereof in medicine
AU2002364468C1 (en) Solid orally-dispersible pharmaceutical formulation
CA2341297A1 (fr) Forme galenique contenant une formulation liquide
CA2283408A1 (fr) Comprimes a avaler contenant du paracetamol
USD313689S (en) Nutritive lollipops
USD321544S (en) Golf ball tee setter

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed